What are the brand names for daptomycin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Brand Names for Daptomycin

The primary brand name for daptomycin is Cubicin, which is the original formulation approved by the FDA 1. A newer reformulated version called Cubicin RF (daptomycin RF) was approved by the FDA in 2016 for the same indications 2.

Key Distinctions Between Formulations

Cubicin RF offers improved stability and more rapid in-vial reconstitution compared to the original Cubicin formulation, while maintaining identical antibacterial coverage and clinical efficacy 2. The reformulation can be reconstituted with either sterile or bacteriostatic water for injection, providing greater flexibility in preparation 2.

Clinical Equivalence

Both formulations are bioequivalent and approved for:

  • Complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria 1, 3
  • Staphylococcus aureus bacteremia, including right-sided infective endocarditis caused by both methicillin-susceptible and methicillin-resistant isolates 1, 3

The choice between Cubicin and Cubicin RF is primarily based on institutional availability and pharmacy preference, as both maintain the same therapeutic profile and dosing regimens 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.